In this way, FcRL3 may play a dual role: enhancing autoantibody production by B cells while also modulating T-cell responses to presented autoantigens, thus reinforcing the immune mechanisms driving the chronic synovial inflammation characteristic of RA (Figure 2) [21]. This evidence concerns the gene FCRL3 and rheumatoid arthritis.